Table 2.
Intervention | No. (%) of participants developing recurrent UTI | Relative risk(95% CI) |
Lactin-V (n = 48) | 7 (15) | .5 (.2–1.2) |
Placebo (n = 48) | 13 (27) | … |
Intervention, L. crispatus colonization pattern | ||
Lactin-V, High level (n = 41) | 2 (5) | .07 (.02–.3) |
Lactin-V, Low level (n = 7) | 5 (71) | … |
Placebo, High level (n = 32) | 9 (28) | 1.1 (.4–3.1) |
Placebo, Low level (n = 16) | 4 (25) | … |
NOTE. CI, confidence interval; Lactin-V, L. crispatus intravaginal suppository probiotic (Osel); UTI, urinary tract infection